| 1/5 | US=8 / Laboratório Hockenbery DM, Korsmeyer SJ. Cell death. In: Hoffman R, Benz EJ Jr, Shattil SJ, Furie B, Silberstein LE, McGlave P, Heslop HE. Hematology: basic principles and practice. 5th ed. Philadelphia: Churchill Livingstone, 2009. p. 72-80. ISBN 978-0-443-06715-0. MORTE CELULAR; TURNOVER CELULAR; RENOVACAO CELULAR EPIDERMICA; RESPOSTA AO DANO CELULAR; APOPTOSE; CASPASES; ATIVACAO DE PRO-CASPASES; APOPTOSSOMAS; BCL-2; BH3; VIAS DE APOPTOSE; DANOS AO DNA; RESPOSTA A PROTEINAS DESDOBRADAS (UPR); ONCOGENE; SINALIZADORAS DE SOBREVIVENCIA |
| 2/5 | US=60 / Biol/Mol Ma S, Chen GG, Lai PBS. Bcl-2 family members in hepatocellular carcinoma (HCC) - mechanisms and therapeutic potentials. In: Chen GG, Lai PBS. Apoptosis in carcinogenesis and chemotherapy: apoptosis in cancer. New York: Springer, 2009. p. 219-35. ISBN 978-1-4020-9596-2. APOPTOSE; MORTE CELULAR PROGRAMADA; FAMILIA BCL-2; DOMINIOS BH3; CARCINOMA HEPATOCELULAR; CANCER DE FIGADO; CANCER HEPATICO; HEPATOCARCINOGENESE |
| 3/5 | US=39 / Câncer Johnson DE. Inhibitors of the Bcl-2 protein family as sensitizers to anticancer agents. In: Bonavida B. Sensitization of cancer cells for chemo/immuno/radio-therapy. Los Angeles: Humana Press, 2008. p. 243-61. ISBN 978-1-58829-989-5. INIBIDORES BCL-2; AGENTES ANTICANCERIGENOS; APOPTOSE; PEPTIDEOS BH3 |
| 4/5 | US=86 / Biol/Mol Moore VDG, Letai A. Rational design of therapeutics targeting the BCL-2 family: are some cancer cells primed for death but waiting for a final push?. In: Khosravi-Far R, White E. Programmed cell death in cancer progression and therapy. New York: Springer, 2008. p. 159-75. (Advances in Experimental Medicina and Biology, 615) ISBN 978-1-4020-6553-8. MORTE CELULAR; APOPTOSE; FAMILIA BCL-2; BH3; TERAPEUTICA; PEPTIDEOS |
| 5/5 | US=2 / Biol/Mol Erlacher M, Michalak EM, Strasser A, Villunger A. Bcl-2 family: the BH3-only proteins puma and noxa: two brothers in arms. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 379-402. ISBN 978-3-527-31237-5. FAMILIA BCL-2; PROTEINAS BH3; PUMA; NOXA; REGULACAO DA P53; MORTE CELULAR |